Boulevard Bio Secures Global Rights to a $1.6B Trispecific T-Cell Engager
Boulevard Bio is paying $20 million upfront and committing up to $1.6 billion in milestones for the global rights to MTS-128, a trispecific T-cell engager.
Month: June 2026
NeuroPulse Wk 26: Cockayne Gene Therapy World-First
NeuroPulse — Wk 26 · 2026 · Synopulse NeuroPulseDeep pine banner. An indigo neural network of neurons and synapses fills the right side, with a gold signal pulse firing along a chain of neurons, beside the NeuroPulse wordmark under the Synopulse and The Pulse kicker. Synopulse · The Pulse NeuroPulse This week in neuroscience Week … Read more
DealFlow: Biopharma Deals This Week June 22–28, 2026
DealFlow Weekly — Wk 26 · 2026 · Synopulse DealFlow WeeklyOn a deep pine background, a faint network of the week’s thirty-five deals fades in while a gold deal line draws across and five gold molecular-ring nodes bloom along it, beside the DealFlow Weekly wordmark and the tagline a weekly readout from Synopulse. SYNOPULSE — … Read more
7 Market Access Trends Reshaping Pharma by 2027
The rules of pharmaceutical market access are being rewritten. From IRA-mandated price ceilings to AI-driven outcomes contracting.